Breakthroughs in research have greatly advanced our understanding of the complement system s role in kidney diseases and has served as the basis for the development of novel therapies that target specific complement components. These innovations have changed the landscape of treatment options for various complement mediated kidney diseases (CMKDs).
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
AAPA Category 1 Credit™Up to 1.5 creditsAMA PRA Category 1 Credit™Up to 1.5 creditsDietetic CPEUsUp to 1.5 creditsNursingUp to 1.5 creditsPharmacyUp to 1.5 creditsSocial WorkUp to 1.5 credits
MOC types
ABIM — Medical KnowledgeUp to 1.5 points
FDA REMS
No
Qualifies for MIPS
No
Target Specialties
Address:
- 30 East 33rd Street
Specialties served/covered
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Enduring / On-demand
- Credit · Up to 1.5 credits
- MOC · Up to 1.5 points
- Commercial Support
-
ReleasedJul 9, 2026
-
Last day to claim creditJul 10, 2027 9 months left
-
Physicians’ Education Resource Burst CME(TM) Part V: Complement Inhibitors in IgAN
-
Medscape, LLC From Bench to Bedside: Prioritizing Early Detection and Complement-Based Interventions in HCT-TMA
-
Global Learning Collaborative Engaging Adult Patients With C3GN: Shared Decision-Making at the Crossroads of Complement-Targeted Therapy
